Leerink downgraded Tekmira Pharmaceuticals Corp. (Nasdaq: TKMR) from an Outperform rating to a Market Perform rating. The stock price plunged $5.53 to close at $24.00.
Tekmira downgraded
October 06, 2014 at 17:25 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.